Human epididymis protein 4 as a potential biomarker of chronic kidney disease in female patients with normal ovarian function

21Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Elevated serum concentrations of human epididymis protein 4 (HE4) have appeared in a large number of female patients with chronic kidney disease (CKD). However, it is unknow whether HE4 could be a potential biomarker for diagnosis of CKD. Objective: To evaluate whether serum HE4 is a potential biomarker of CKD in our cohort of 238 ethnic Han Chinese female patients, between the ages of 19 and 89 years. Methods: We selected 230 healthy control individuals and 238 female patients with CKD for inclusion in our study. We acquired their demographic characteristics and evaluated their renal function by measuring serum creatinine, blood urea nitrogen, and uric acid levels. The serum concentrations of HE4 were quantified via chemiluminescence immunoassay. Results: Serum HE4 levels were significantly higher in the patients with CKD compared with controls (P

Cite

CITATION STYLE

APA

Yuan, T., & Li, Y. (2017). Human epididymis protein 4 as a potential biomarker of chronic kidney disease in female patients with normal ovarian function. Lab Medicine, 48(3), 238–243. https://doi.org/10.1093/labmed/lmx036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free